Clearside Biomedical Inc Total Liabilities

Latest as of September 2025: $65.59 Million USD

Clearside Biomedical Inc total liabilities. Based on the latest financial reports, Clearside Biomedical Inc (CLSD) has total liabilities worth $65.59 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CLSD asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Clearside Biomedical Inc (2012–2024)

Total liabilities of Clearside Biomedical Inc from 2012 to 2024. This chart illustrates how Clearside Biomedical Inc's total liabilities have evolved over time, based on quarterly financial data.

Clearside Biomedical Inc Competitors by Total Liabilities

The table below lists competitors of Clearside Biomedical Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Lucapa Diamond Co Ltd F:NHY	Germany	€2.88 Million
Candela Invest SA BR:CAND	Belgium	€6.11 Million
NewGenIvf Group Limited Class A Ordinary Shares NASDAQ:NIVF	USA	$6.74 Million
Global Battery Metals Ltd V:GBML	Canada	CA$1.03 Million
Australian Bond Exchange Holdings Ltd AU:ABE	Australia	AU$6.83 Million
Silver Bull Resources Inc TO:SVB	Canada	CA$8.59 Million
Miramar Resources Ltd AU:M2R	Australia	AU$835.67K
Edible Garden AG Inc NASDAQ:EDBL	USA	$8.65 Million

Liability Composition Analysis (2012–2024)

This chart breaks down Clearside Biomedical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Clearside Biomedical Inc balance sheet assets.

Liquidity & Leverage Metrics

Clearside Biomedical Inc Total Liabilities Ratios Explained

Clearside Biomedical Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	2.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.22	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	5.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Clearside Biomedical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Clearside Biomedical Inc (2012–2024)

The table below shows the annual total liabilities of Clearside Biomedical Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	$63.98 Million	+28.14%
2023-12-31	$49.93 Million	+22.69%
2022-12-31	$40.70 Million	+725.81%
2021-12-31	$4.93 Million	-53.33%
2020-12-31	$10.56 Million	-32.40%
2019-12-31	$15.62 Million	-23.81%
2018-12-31	$20.50 Million	+7.45%
2017-12-31	$19.08 Million	+45.04%
2016-12-31	$13.15 Million	-77.21%
2015-12-31	$57.71 Million	+95.56%
2014-12-31	$29.51 Million	+129.22%
2013-12-31	$12.88 Million	+1715.94%
2012-12-31	$709.00K	--

About Clearside Biomedical Inc

NASDAQ:CLSD USA Biotechnology

Market Cap

$2.15 Million

Market Cap Rank

#29978 Global

#6122 in USA

Share Price

$0.41

Change (1 day)

-26.96%

52-Week Range

$0.41 - $4.09

All Time High

$24.72